For PD-L1 expression, B cells from the healthy control group showed little expression of PD-L1, B-cells from patients with stage I and II melanoma showed detectable low PD-L1, and naive B cells from stage III and IV showed moderate PD-L1. Here, CD274 is linked to melanoma.